Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 5;10(11):4055-4064.
doi: 10.1016/j.ekir.2025.08.041. eCollection 2025 Nov.

CKD Prevalence and Associated Factors in Jamaica

Affiliations

CKD Prevalence and Associated Factors in Jamaica

Lori-Ann M Fisher et al. Kidney Int Rep. .

Abstract

Introduction: Jamaica has a high attributable burden of chronic kidney disease (CKD) but no population-based prevalence estimates. We aimed to estimate the prevalence of CKD and explore associated factors.

Methods: A secondary analysis of data from Jamaican residents aged ≥ 15 years from the nationally representative Jamaica Health and Lifestyle Survey-III was performed. CKD was defined as an estimated glomerular filtration rate (eGFR) < 60 ml/min per 1.73 m2, using the CKD Epidemiology Collaboration 2021 or Schwartz-Lyon equations, and/or urine albumin-to-creatinine ratio (UACR) ≥ 30 mg/g. Associated factors included age, sex, socioeconomic status (SES), education level, body mass index (BMI), hypertension, diabetes mellitus, and sickle cell trait (SCT). Weighted prevalence estimates were determined, accounting for survey design. Multivariable logistic regression was used to evaluate CKD associations.

Results: Analyses included 583 individuals, 366 females, mean ± SD age was 49.0 ± 18.2 years. CKD prevalence was 14.8% (95% confidence interval [CI]: 11.5%-18.9%). Seven percent (7.2% (95% CI: 5.1%-10.1%) had CKD stage 3 or higher and 8.8% (95% CI: 6.3%-12.0%) had albuminuria. Individuals with CKD were older (mean age: 57 vs. 46.3 years, P < 0.001), had higher mean systolic blood pressure (140.3 mm Hg vs. 128.3 mm Hg, P < 0.001), and fasting glucose (6.7 vs. 5.8 mM/l, P < 0.001). In a multivariable regression model, hypertension (odds ratio [OR]: 2.14, 95% CI: 1.22-3.75), diabetes mellitus (OR: 2.39, 95% CI: 1.36-4.19), hemoglobin AC genotype (OR: 2.14, 95% CI: 0.64-7.13) were associated with higher odds of CKD, whereas higher education level with lower odds of CKD (OR: 0.47, 95% CI: 0.25-0.89) and (OR: 0.41, 95% CI: 0.18-0.96) for secondary and tertiary education, respectively.

Conclusion: CKD prevalence was estimated at 15%. This may translate to increased burden on the Jamaican health system.

Keywords: Caribbean; Jamaica; chronic kidney disease; health-disparities; hypertension.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
Prevalence of CKD stages by Kidney Disease Improving Global Outcomes risk categories. Bold is percentages based on weighted estimates, with 95% confidence intervals in brackets. CKD, Chronic kidney disease; GFR, glomerular filtration rate; A1, urine albumin creatinine ratio (UACR) <30mg/g; A2, UACR 30-300mg/g; A3, UACR >300mg/g; G1, GFR ≧90mL/min/1.73m2; G2, 60-89 mL/min/1.72m2; G3a, GFR 45-59mL/min/1.73m2; G3b, GFR 30-44mL/min/1.73m2; G4, 15-29mL/min/1.73m2; G5, <15 mL/min/1.73m2.
Figure 2
Figure 2
Frequency of chronic kidney disease by 10-year age categories.

References

    1. Global Burden of Disease Chronic Kidney Disease Collaboration Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709–733. doi: 10.1016/S0140-6736(20)30045-3. - DOI - PMC - PubMed
    1. Francis A., Harhay M.N., Ong A.C.M., et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20:473–485. doi: 10.1038/s41581-024-00820-6. - DOI - PubMed
    1. Stevens P.E., Ahmed S.B., Carrero J.J. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117–S314. doi: 10.1016/j.kint.2023.10.018. - DOI - PubMed
    1. Writing group for the CKD Prognosis Consortium, Grams M.E., Coresh J., et al. Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis. JAMA. 2023;330:1266–1277. doi: 10.1001/jama.2023.17002. - DOI - PMC - PubMed
    1. Thomas B., Matsushita K., Abate K.H., et al. Global cardiovascular and renal outcomes of reduced GFR. J Am Soc Nephrol. 2017;28:2167–2179. doi: 10.1681/ASN.2016050562. - DOI - PMC - PubMed

LinkOut - more resources